Exosome origin determines cell targeting and the transfer of therapeutic nanoparticles towards target cells

Sancho-Albero, M. (Universidad de Zaragoza) ; Navascués, N. ; Mendoza, G. (Universidad de Zaragoza) ; Sebastián, V. (Universidad de Zaragoza) ; Arruebo, M. (Universidad de Zaragoza) ; Martín-Duque, P. ; Santamaría, J. (Universidad de Zaragoza)
Exosome origin determines cell targeting and the transfer of therapeutic nanoparticles towards target cells
Financiación FP7 / Fp7 Funds
Resumen: Background: Exosomes are considered key elements for communication between cells, but very little is known about the mechanisms and selectivity of the transference processes involving exosomes released from different cells.
Results: In this study we have investigated the transfer of hollow gold nanoparticles (HGNs) between different cells when these HGNs were loaded within exosomes secreted by human placental mesenchymal stem cells (MSCs). These HGNs were successfully incorporated in the MSCs exosome biogenesis pathway and released as HGNs-loaded exosomes. Time-lapse microscopy and atomic emission spectroscopy allowed us to demonstrate the selective transfer of the secreted exosomes only to the cell type of origin when studying different cell types including cancer, metastatic, stem or immunological cells.
Conclusions: In this study we demonstrate the selectivity of in vitro exosomal transfer between certain cell types and how this phenomenon can be exploited to develop new specific vectors for advanced therapies. Specifically, we show how this preferential uptake can be leveraged to selectively induce cell death by light-induced hyperthermia only in cells of the same type as those producing the corresponding loaded exosomes. We describe how the exosomes are preferentially transferred to some cell types but not to others, thus providing a better understanding to design selective therapies for different diseases.[Figure not available: see fulltext.]

Idioma: Inglés
DOI: 10.1186/s12951-018-0437-z
Año: 2019
Publicado en: Journal of Nanobiotechnology 17, 1 (2019), 16 [13 pp]
ISSN: 1477-3155

Factor impacto JCR: 6.518 (2019)
Categ. JCR: BIOTECHNOLOGY & APPLIED MICROBIOLOGY rank: 15 / 156 = 0.096 (2019) - Q1 - T1
Categ. JCR: NANOSCIENCE & NANOTECHNOLOGY rank: 30 / 103 = 0.291 (2019) - Q2 - T1

Factor impacto SCIMAGO: 1.335 - Applied Microbiology and Biotechnology (Q1) - Bioengineering (Q1) - Biomedical Engineering (Q1) - Pharmaceutical Science (Q1) - Medicine (miscellaneous) (Q1) - Nanoscience and Nanotechnology (Q2) - Molecular Medicine (Q2)

Financiación: info:eu-repo/grantAgreement/EC/FP7/614715/EU/A Photo-triggered On-demand Drug Delivery System for Chronic Pain/NANOHEDONISM
Financiación: info:eu-repo/grantAgreement/ES/ISCIII/CIBER-BBN
Tipo y forma: Article (Published version)
Área (Departamento): Área Ingeniería Química (Dpto. Ing.Quím.Tecnol.Med.Amb.)

Creative Commons You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.


Exportado de SIDERAL (2021-01-08-08:04:02)

Este artículo se encuentra en las siguientes colecciones:
Articles



 Record created 2019-02-19, last modified 2021-01-08


Versión publicada:
 PDF
Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)